October 2025 in “Journal of Advanced Trends in Medical Research” This review discusses the potential of platelet-rich plasma and exosome-based therapies for treating various types of alopecia, highlighting their promise but noting the need for more research on standardization and efficacy.
This review reported that alopecia prevalence and psychosocial impacts vary significantly among migrant and ethnic minority communities due to diverse genetic, environmental, and cultural factors, highlighting needs for culturally competent care and stigma reduction to address disparities and improve access.
April 2025 in “European Journal of Pharmaceutics and Biopharmaceutics” This study developed and tested Bicalutamide-loaded lipid vesicles in dissolving microarray patches for topical application, finding that they effectively deliver Bicalutamide through murine skin while maintaining a favorable safety profile, suggesting potential to improve treatments for androgenetic alopecia.
November 2024 in “Psychology Health & Medicine” This study identified subgroups of people with alopecia areata with varying levels of quality of life impairment, influenced by feelings of flaw, coping styles, and social factors.
December 2023 in “Journal of dermatology” This study found that adult and adolescent patients with alopecia areata in the US and Europe are willing to accept significant risks of serious side effects, such as infection and cancer, to achieve effective hair regrowth with Janus kinase inhibitors.
November 2023 in “Computational and Structural Biotechnology Journal” This study reports the development of a prototype robotic hair transplant system capable of efficiently harvesting and implanting hair grafts, showing promising accuracy and performance in tests using a spherical scalp phantom.
October 2023 in “Journal of the European Academy of Dermatology and Venereology” This source outlines the WHO's framework for meaningful engagement of individuals with lived experience of noncommunicable diseases and dermatological conditions, emphasizing eliminating stigma, promoting inclusion, and redistributing power to improve health policies and support systems.
July 2023 in “Deleted Journal” This study reported a higher prevalence of androgenetic alopecia in male respondents compared to female respondents in different regions of Saudi Arabia.
4 citations
,
July 2024 in “Radiotherapy and Oncology” This study highlights that variations in clinical outcome reporting can undermine the validation of NTCP models for RIA, stressing the need for a standardized and objective scoring system.
June 2024 in “Skin Health and Disease” This study found that most men with alopecia experience significant psychosocial concerns, such as depleted confidence and lower wellbeing, yet seldom seek support, suggesting a disconnect likely influenced by masculine norms, particularly impacting those identifying as sexual minorities.
61 citations
,
April 2021 in “Frontiers in Medicine” This study found that hidradenitis suppurativa significantly impaired quality of life in German patients, with severity linked to skin and certain extra-cutaneous changes, but not reduced by surgical or conventional medicamentous treatments.
38 citations
,
March 2021 in “JAMA Dermatology” This cross-sectional survey study found that stigmatizing attitudes toward people with alopecia are present in various social and professional settings, with stigma levels varying by alopecia severity and perceptions of its medical nature.
20 citations
,
April 2023 in “Frontiers in Public Health” This study found that psychological and social reporting after trauma with scarring can indicate a person's reaction and susceptibility to psychopathology.
18 citations
,
September 2024 in “Journal of the European Academy of Dermatology and Venereology” This review found that the DLQI is widely used as a benchmark in the development and validation of dermatology quality-of-life measures.
8 citations
,
January 2014 in “Human Development” This article reviews Miriam Arbeit's skill-based model for promoting adolescent sexual development, highlighting its focus on adolescents as active participants in their own sexual growth but noting areas for further expansion.
2 citations
,
December 2023 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” This study, involving an international panel of 16 psychodermatology experts, proposed a new classification system for psychodermatology disorders that aims to unify previous classifications and improve their management by systematizing disorders into two main categories: primary mental health disorders and primary skin disorders.
1 citations
,
January 2023 in “Acta dermato-venereologica” This study found that individuals with alopecia areata in Germany, Austria, and Switzerland face significant out-of-pocket costs averaging 1,248€ annually, primarily for hair replacement products and cosmetics.
August 2026 in “Journal of Clinical Medicine” In this study, researchers found that the management of alopecia areata in Poland is inadequate, despite following international guidelines, due to limited access to advanced treatments and insufficient use of severity assessments and psychosocial support.
January 2026 in “Cosmetics” This study highlights emerging regenerative strategies, such as stem cell-derived therapies and machine learning tools, that may advance hair loss treatment beyond traditional methods by promoting follicle regeneration and offering personalized care.
August 2025 in “Aesthetic Plastic Surgery” This review explores the mechanisms, current products, challenges, and innovative approaches related to cosmetics for hair loss prevention and growth promotion, emphasizing the need for multidisciplinary cooperation to enhance product development and market success.
May 2024 in “Psychiatric News” In this study, analysis of electronic health records suggested that patients taking semaglutide were significantly less likely to experience suicidal ideation compared to those on non-GLP-1 obesity or diabetes medications.
5 citations
,
May 2024 in “Australasian Journal of Dermatology” This study found that alopecia areata significantly impacts both emotional and psychosocial well-being, leading to impaired productivity in adults and adolescents, especially those experiencing more extensive hair loss.
2 citations
,
September 2022 in “Indian Journal of Dermatology, Venereology and Leprology” This study identified common dermatological issues and procedures among transgender individuals in India, highlighting insufficient access to dermatological services and distinct cosmetic concerns related to hormone and surgery changes during transition.
February 2025 in “Journal of Women & Aging” This study identified a significant trend among Black women towards less frequent use of complex hairstyles and salon visits over 30 years, while managing grey hair became a key element of personal and social identity.
10 citations
,
January 2023 in “Journal of the European Academy of Dermatology and Venereology” This review highlights the significant negative impact of alopecia areata on quality of life, mental health, and work, calling for individualized approaches and effective treatments to mitigate these effects.
November 2025 in “Skin Health and Disease” This study found that patients with alopecia areata had a higher prevalence of depression, anxiety, and alexithymia compared to normative data, with alexithymia more common in those with earlier onset AA, lower education levels, and younger age.
202 citations
,
January 2022 in “Journal of Clinical Medicine” This study found that female COVID-19 survivors were more likely than males to experience multiple long-term post-COVID symptoms, including fatigue, pain, hair loss, and mood disorders.
105 citations
,
March 2006 in “Human reproduction” This study found that metformin treatment improved health-related quality-of-life, emotional well-being, and sexual satisfaction among women with PCOS, correlated with weight loss and menstrual cycle normalization.
61 citations
,
March 2022 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” This study found that 43.35% of the adult population across 27 European countries reported having a skin condition in the past year, highlighting the need for dermatological care planning.
40 citations
,
October 2017 in “Acta Dermato Venereologica” This study found that illness perception, as measured by the Revised Illness Perception Questionnaire, was significantly associated with health-related quality of life in patients with primary cutaneous T- and B-cell lymphomas.